Cargando…
Foveal structure during the induction phase of anti-vascular endothelial growth factor therapy for occult choroidal neovascularization in age-related macular degeneration
PURPOSE: To evaluate the efficacy of monthly injections of aflibercept and ranibizumab on foveal structure after three months, for the treatment of occult choroidal neovascularization (CNV) in age-related macular degeneration (AMD). METHODS: We retrospectively studied 103 eyes with treatment-naïve n...
Autores principales: | Kano, Mariko, Sekiryu, Tetsuju, Sugano, Yukinori, Oguchi, Yasuharu, Ojima, Akira, Itagaki, Kanako, Saito, Masaaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639548/ https://www.ncbi.nlm.nih.gov/pubmed/26604674 http://dx.doi.org/10.2147/OPTH.S90932 |
Ejemplares similares
-
Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
por: Itagaki, Kanako, et al.
Publicado: (2020) -
Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease
por: Tanaka, Keiichiro, et al.
Publicado: (2021) -
Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
por: Kato, Yutaka, et al.
Publicado: (2020) -
Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration
por: Kato, Yutaka, et al.
Publicado: (2022) -
Retinal pigment epithelium tear after intravitreal aflibercept injection
por: Saito, Masaaki, et al.
Publicado: (2013)